The protein DAZAP1 plays "master regulator" role in how genes are expressed in cancer
5/01/2014
Researchers in the UNC School of Medicine found that the protein DAZAP1 plays a key role in the regulation of many genes through a process known as alternative splicing, and when highly expressed in...
A new strategy to personalise cancer therapies
5/01/2014
Tumour cells can accumulate hundreds or even thousands of DNA mutations which induce the growth and spread of cancer.
New goals for global health research and training
5/01/2014
Global health research and training efforts should focus on combatting the growing epidemic of noncommunicable diseases, better incorporating information technology into research and training, and...
Vitamin D deficiency may predict aggressive prostate cancer
5/01/2014
New research has found that men with low levels of vitamin D, particularly African-American men, may be at increased risk of aggressive prostate cancer.
New approach to immunotherapy could increase cancer patient survival
5/01/2014
Developing immunotherapies for cancer is challenging because of significant variability among tumors and diversity in human immune types.
Among breast, colorectal and other cancers, Vitamin D may raise survival rates
5/01/2014
Cancer patients who have higher levels of vitamin D when they are diagnosed tend to have better survival rates and remain in remission longer than patients who are vitamin D-deficient, according to a...
Managing surgical patients taking new drugs to prevent blood clots
5/01/2014
New oral anticoagulant drugs that treat and prevent clots offer a much-needed alternative to warfarin, which has been used for more than 6 decades and has serious shortcomings.
CT in the operating room allows more precise removal of small lung cancers
4/30/2014
A new technique that brings CT imaging into the operating room will allow surgeons to precisely demarcate and remove small sub-centimeter lung nodules, leaving as much healthy tissue as possible...
Cell Therapeutics, Inc. has announced the launch of PIXUVRI® (pixantrone), the first new treatment for adult patients in the United Kingdom (UK) with multiply relapsed or refractory aggressive...
GW Pharmaceuticals announces that Sativex receives fast track designation from FDA in cancer pain
4/30/2014
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, has announced that...